Novo Nordisk Inc.

Form 483

Plainsboro, New Jersey, United StatesFEI 2244771Issued April 13, 2017

View FDA's Record for This Firm

Source: FDA inspection record. Confirmed against FDA's published inspection data for this establishment and inspection date. FDA has published the inspection and what it cited, but not the form itself, which usually takes six to twelve months. To check it, open FDA's record for this establishment on FDA's Data Dashboard, listed under FEI 2244771.

Observations1

Issue DateApril 13, 2017

Status2 Related Warning Letters

Related Inspections10

Establishment Details

Firm: Novo Nordisk Inc.
Location: Plainsboro, New Jersey, United States
FEI Number: 2244771
Product Type: Drugs
Issue Date: April 13, 2017
Country: United States

Inspection History, 2008 to 2025

NAI8

VAI1

OAI1

NAI means No Action Indicated. VAI means Voluntary Action Indicated. OAI means Official Action Indicated.

Act on This Form 483

FDA Inspection ReadinessSee how your operations would hold up to the same scrutiny.CAPA & InvestigationsScore how you would investigate and close findings like these.Talk to a SpecialistWalk through these observations with a ComplianceQuest expert.

Novo Nordisk Inc. FDA Form 483, Plainsboro, New Jersey, April 13, 2017